tradingkey.logo
tradingkey.logo
Buscar

Bain Capital Specialty Finance Inc

BCSF
Añadir a la lista de seguimiento
12.630USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
819.94MCap. mercado
11.13P/E TTM

Más Datos de Bain Capital Specialty Finance Inc Compañía

Bain Capital Specialty Finance, Inc. is an externally managed specialty finance company focused on lending to middle market companies. The Company's investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including first lien, first lien/last out, unitranche and second lien debt, investments in strategic joint ventures, equity investments and, to a lesser extent, corporate bonds. Its primary focus is capitalizing on opportunities within Bain Capital Credit's Senior Direct Lending Strategy, which seeks to provide risk-adjusted returns and current income to investors by investing primarily in middle-market direct lending opportunities across North America, Europe and Australia and also in other geographic markets. It may also invest in mezzanine debt and other junior securities, including common and preferred equity and in secondary purchases of assets or portfolios. It is managed by BCSF Advisors, LP.

Información de Bain Capital Specialty Finance Inc

Símbolo de cotizaciónBCSF
Nombre de la empresaBain Capital Specialty Finance Inc
Fecha de salida a bolsaNov 15, 2018
Director ejecutivoEwald (Michael A)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 15
Dirección200 Clarendon Street
CiudadBOSTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02116
Teléfono16175162000
Sitio Webhttps://baincapitalspecialtyfinance.com/
Símbolo de cotizaciónBCSF
Fecha de salida a bolsaNov 15, 2018
Director ejecutivoEwald (Michael A)

Ejecutivos de Bain Capital Specialty Finance Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael A. Ewald
Mr. Michael A. Ewald
Chief Executive Officer, Director
Chief Executive Officer, Director
216.02K
+17.89%
Mr. Jeffrey B. Hawkins, J.D.
Mr. Jeffrey B. Hawkins, J.D.
Chairman of the Board
Chairman of the Board
100.00K
--
Mr. Thomas A. Hough, CPA
Mr. Thomas A. Hough, CPA
Independent Director
Independent Director
41.94K
+8.70%
Ms. Amy Butte
Ms. Amy Butte
Independent Director
Independent Director
6.25K
--
Mr. David G. Fubini
Mr. David G. Fubini
Independent Director
Independent Director
--
--
Mr. Jay Margolis ,
Mr. Jay Margolis ,
Independent Director
Independent Director
--
--
Mr. James Goldman, J.D.
Mr. James Goldman, J.D.
Chief Compliance Officer
Chief Compliance Officer
--
--
Mr. Michael J. Boyle
Mr. Michael J. Boyle
President, Director
President, Director
--
--
Ms. Clare S. Richer
Ms. Clare S. Richer
Independent Director
Independent Director
--
--
Mr. Amit Joshi
Mr. Amit Joshi
Chief Financial Officer
Chief Financial Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael A. Ewald
Mr. Michael A. Ewald
Chief Executive Officer, Director
Chief Executive Officer, Director
216.02K
+17.89%
Mr. Jeffrey B. Hawkins, J.D.
Mr. Jeffrey B. Hawkins, J.D.
Chairman of the Board
Chairman of the Board
100.00K
--
Mr. Thomas A. Hough, CPA
Mr. Thomas A. Hough, CPA
Independent Director
Independent Director
41.94K
+8.70%
Ms. Amy Butte
Ms. Amy Butte
Independent Director
Independent Director
6.25K
--
Mr. David G. Fubini
Mr. David G. Fubini
Independent Director
Independent Director
--
--
Mr. Jay Margolis ,
Mr. Jay Margolis ,
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Bain Capital Specialty Finance Inc?

Los cinco principales accionistas de Bain Capital Specialty Finance Inc son: Mr. Michael A. Ewald

¿Cuántas instituciones poseen acciones de Bain Capital Specialty Finance Inc (BCSF)?

A fecha de 2026Q1, 279 instituciones poseen acciones de Bain Capital Specialty Finance Inc, con un valor de mercado combinado de aproximadamente 37.06M, lo que representa el 57.13% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 531426.00.